Target intelligence / Profile preview

Coagulation factor IX (F9 protein) (FIX or Factor IX)

Target
FIX or Factor IX
Molecular classification
Serine protease, Enzyme, Vitamin K-dependent plasma glycoprotein, Peptidase family S1, Blood coagulation factor
01

Overview

Coagulation factor IX (FIX), commonly known as the Christmas factor, is a vitamin K-dependent serine protease that plays a crucial role in the intrinsic pathway of blood coagulation. The protein was discovered in 1952 when a young boy named Stephen Christmas was identified as lacking this clotting factor, and the discovery was published in a Christmas edition of the British Medical Journal, giving the protein its distinctive name. Factor IX functions by cleaving and activating Factor X, working in conjunction with its cofactor Factor VIII to form a membrane-bound complex that generates thrombin and ultimately leads to fibrin clot formation. Deficiency of Factor IX causes hemophilia B (Christmas disease), a rare X-linked recessive bleeding disorder that accounts for approximately 20% of all hemophilia cases. The condition results from mutations in the F9 gene, with over 3,000 variants described that affect various residues of the protein. Treatment involves recombinant Factor IX or plasma-derived Factor IX replacement therapy, which has transformed the clinical management of hemophilia B patients. A significant therapeutic challenge is the development of inhibitors to Factor IX in some patients, limiting treatment effectiveness and necessitating alternative therapeutic approaches. Additionally, Factor IX represents an attractive target for anticoagulation drugs designed to prevent thrombosis by interfering with its interactions with other coagulation factors.

Other names
Christmas factorChristmas disease factorplasma thromboplastic componentcoagulation factor IX humanblood-coagulation factor IXplasma thromboplatin componentantihemophilic factor B
02

Mechanism of action

Cleaves peptide bonds in Factor X, converting it to its activated form (Factor Xa). Functions as part of the intrinsic coagulation pathway feedback loop, where Factor IXa works with Factor VIIIa cofactor in a membrane-bound complex to activate Factor X. Requires calcium ions, membrane phospholipids, and Factor VIII cofactor for physiological activity. Operates through a serine protease catalytic mechanism involving a catalytic triad of Asp, His, and Ser residues.

03

Biological functions

Blood coagulation/hemostasisIntrinsic pathway of blood coagulation cascadeActivation of clotting factor XSerine protease activity through peptide bond cleavageCalcium-dependent phospholipid binding
04

Disease associations

Hemophilia B (Christmas disease) - caused by deficiency or dysfunction of Factor IXBleeding disordersThrombosis prevention (as a therapeutic target for anticoagulation drugs)
05

Safety considerations

Development of inhibitors to Factor IX replacement therapy is a major clinical problem in hemophilia B patients, limiting treatment efficacyThrombotic risk with prolonged or excessive dosingRisk of uncontrolled bleeding if Factor IX is over-inhibited therapeutically
06

Interacting drugs

Recombinant factor IX formulations (used as replacement therapy for hemophilia B)

4 more in the full profile.

07

Biomarkers

Factor IX assay/activity levels (for diagnosis and monitoring of hemophilia B)F9 gene sequencing (for identification of mutations causing hemophilia B)Factor IX inhibitor presence in patients (complication monitoring)

Beyond the preview

Go deeper on Coagulation factor IX (F9 protein) (FIX or Factor IX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coagulation factor IX (F9 protein) (FIX or Factor IX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call